Sign In

Mark Smith

CEO at Finch

Mark Smith is a computational microbiologist with a passion for unlocking the potential of the microbiome to enhance human health.

With a Doctor of Philosophy degree in Microbiology from Massachusetts Institute of Technology and an A.B. in Biology from Princeton University, Mark has a strong academic foundation.

He currently serves as the CEO of Finch Therapeutics Group and has previously been involved in founding and directing research at OpenBiome.

Mark is dedicated to investigating the intricate relationships between humans and their microbial communities and is enthusiastic about developing therapeutic solutions to address critical medical needs.

Highlights

Jan 24 · linkedin

Today Finch made the difficult decision to stop our Phase 3 trial in C. difficile and initiate a restructuring that will impact most of our team. I’m writing to speak to the remarkable character of the individuals that comprise this team. These are the kind of teammates who respond to this incredibly disappointing news by asking how they can help ensure that the technology is best positioned to potentially serve patients in the future. If anyone in my network is recruiting in the life sciences, I can make strong recommendations for folks on our team that will be looking for their next opportunity to transform patient care. Please drop me a note, or email [email protected], if you would like to get a copy of our resume book and if you see Finch Therapeutics pop up on a Resume you are reviewing, know that you are looking at a very talented professional with a tenacious commitment to bringing novel, life-changing therapies to patients. I want to wish all our transitioning teammates the best and sincerely thank the entire Finch community for the many contributions they’ve made to our mission and this emerging new field of medicine.

M
Add to my network

Location

United States